• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by HUTCHMED (China) Limited

    6/10/25 6:37:47 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $HCM alert in real time by email
    6-K 1 hcm-20250610x6k.htm 6-K

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    ​


    ​

    FORM 6-K

    ​


    ​

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

    SECURITIES EXCHANGE ACT OF 1934

    ​

    For the Month of June 2025

    ​

    Commission File Number: 001-37710

    ​


    ​

    HUTCHMED (CHINA) LIMITED

    (Translation of registrant’s name into English)

    ​


    ​

    48th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong

    (Address of principal executive offices)

    ​


    ​

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    ​

    Form 20-F  ⌧             Form 40-F  ◻

    ​

    ​

    ​

    ​


    ​

    HUTCHMED (CHINA) LIMITED

    ​

    Form 6-K

    ​

    EXHIBIT INDEX

    ​

    Exhibit No.

        

    Description

    ​

    ​

    ​

    Exhibit 99.1

    ​

    Announcement relating to grant of share options under Share Option Scheme and awards under Long Term Incentive Plan

    2


    ​

    ​

    SIGNATURE

    ​

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    ​

    ​

    ​

    HUTCHMED (CHINA) LIMITED

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    By:

    /s/ Johnny Cheng

    ​

    Name:

    Johnny Cheng

    ​

    Title:

    Chief Financial Officer

    ​

    ​

    Date: June 10, 2025

    3


    Get the next $HCM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HCM

    DatePrice TargetRatingAnalyst
    5/13/2025Buy → Hold
    HSBC Securities
    11/24/2023Hold → Buy
    Deutsche Bank
    5/4/2022Buy → Hold
    Deutsche Bank
    9/22/2021$46.00Buy → Neutral
    Goldman
    8/3/2021$52.00Buy
    Jefferies
    More analyst ratings